GILEAD SCIENCES, INC. is 79.1x more valuable than Vericel Corp by market capitalization ($151.05 B vs $1.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VCEL | GILD |
|---|---|---|
| Market cap | $1.91 B | $151.05 B |
| US-listed rank | #2121 | #99 |
| Revenue (latest FY) | $276.26M | $29.44B |
| Net income (latest FY) | $16.52M | $8.51B |
| Net margin | 6.0% | 28.9% |
| P/E (trailing FY) | 115.6 | 17.7 |
| SEC filings | 1,674 | 981 |
GILEAD SCIENCES, INC. is 79.1x more valuable than Vericel Corp by market capitalization ($151.05 B vs $1.91 B).
In their latest fiscal years, Vericel Corp reported $276.26M in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: Vericel Corp and GILEAD SCIENCES, INC., or browse the full rankings.